Evaluating the Association between Assisted Conception and the Severity of Preeclampsia
Table 3
Demographics within preeclamptics.
Variable
Assistedβ ββ% ()
Unassistedβ‘ββ% ()
value
Mean age
37.3 +/β 5
26.4 +/β 6.7
<0.001
Race (African American)
18.8 (3)
87.3 (370)
<0.0001
Mean BMI at screening
27.8 +/β 6.8
30 +/β 8
0.31
Primiparous
75 (12)
50.5 (214)
0.095
Gestational age at delivery
33.8 +/β 4.2
36.1 +/β 3.7
0.01
Twin pregnancy
56.3 (9)
3.1 (13)
<0.0001
Pregestational diabetes
0
4.3 (18)
0.84
Gestational diabetes
6.3 (1)
3.8 (16)
0.88
Chronic hypertension
6.3 (1)
15.8 (67)
0.49
History of preeclampsia
18.8 (3)
21.0 (89)
0.93
History of preterm preeclampsia
6.3 (1)
11.8 (50)
0.78
Tobacco use
0
12.5 (53)
0.26
β Assisted pregnancies included use of clomiphene citrate, gonadotropins, IUI, IVF, ICSI, and donor egg, β‘Women with unassisted pregnancies did not report use of clomiphene citrate, gonadotropins, IUI, IVF, ICSI, or donor egg for conception.
We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.
